David Azria

Title: David Azria: Innovator in Radiosensitivity Determination

Introduction

David Azria is a notable inventor based in Fontanes, France. He has made significant contributions to the field of medical research, particularly in the area of radiosensitivity. His innovative approach has the potential to enhance the understanding of how individuals respond to radiation therapy.

Latest Patents

David Azria holds a patent for a method that determines radiosensitivity. The patent describes a method for the in vitro determination of a subject's radiosensitivity. This method involves inducing an exogenous stress on a biological sample from a subject, followed by comparing the presence or level of at least one compound from a defined group in the biological sample and a reference sample. The invention also identifies the use of these compounds as predictive biomarkers of a subject's radiosensitivity. Additionally, it includes a kit for detecting the presence or level of these compounds, which can be utilized in the described method. He has 1 patent to his name.

Career Highlights

Throughout his career, David Azria has worked with esteemed institutions such as the Centre Hospitalier Universitaire de Montpellier and Université de Montpellier. His work in these organizations has allowed him to collaborate with other professionals in the field and contribute to significant advancements in medical research.

Collaborations

David Azria has collaborated with notable colleagues, including Jérôme Solassol and Alain Mange. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

David Azria's contributions to the field of radiosensitivity determination highlight his role as an innovator in medical research. His patented method and collaborations with esteemed institutions and colleagues underscore the importance of his work in advancing our understanding of radiation therapy.